These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16392821)

  • 21. Systematic development of high affinity bis(ammonio)alkane-type allosteric enhancers of muscarinic ligand binding.
    Muth M; Bender W; Scharfenstein O; Holzgrabe U; Balatkova E; Tränkle C; Mohr K
    J Med Chem; 2003 Mar; 46(6):1031-40. PubMed ID: 12620079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum.
    Ringdahl B
    J Pharmacol Exp Ther; 1985 Jan; 232(1):67-73. PubMed ID: 3965701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
    Gharagozloo P; Lazareno S; Popham A; Birdsall NJ
    J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A; Christopoulos A; Mitchelson F
    J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
    Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
    Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.
    Zahn K; Eckstein N; Tränkle C; Sadée W; Mohr K
    J Pharmacol Exp Ther; 2002 May; 301(2):720-8. PubMed ID: 11961078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivity.
    Schmitz J; van der Mey D; Bermudez M; Klöckner J; Schrage R; Kostenis E; Tränkle C; Wolber G; Mohr K; Holzgrabe U
    J Med Chem; 2014 Aug; 57(15):6739-50. PubMed ID: 25051097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.
    Böhme TM; Keim C; Kreutzmann K; Linder M; Dingermann T; Dannhardt G; Mutschler E; Lambrecht G
    J Med Chem; 2003 Feb; 46(5):856-67. PubMed ID: 12593665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenyl-substituted analogues of oxotremorine as muscarinic antagonists.
    Nilsson BM; Vargas HM; Ringdahl B; Hacksell U
    J Med Chem; 1992 Jan; 35(2):285-94. PubMed ID: 1732545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity.
    Antony J; Kellershohn K; Mohr-Andrä M; Kebig A; Prilla S; Muth M; Heller E; Disingrini T; Dallanoce C; Bertoni S; Schrobang J; Tränkle C; Kostenis E; Christopoulos A; Höltje HD; Barocelli E; De Amici M; Holzgrabe U; Mohr K
    FASEB J; 2009 Feb; 23(2):442-50. PubMed ID: 18842964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.
    Minarini A; Marucci G; Bellucci C; Giorgi G; Tumiatti V; Bolognesi ML; Matera R; Rosini M; Melchiorre C
    Bioorg Med Chem; 2008 Aug; 16(15):7311-20. PubMed ID: 18595721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of the muscarinic toxin MT7 on agonist-bound muscarinic M1 receptors.
    Olianas MC; Adem A; Karlsson E; Onali P
    Eur J Pharmacol; 2004 Mar; 487(1-3):65-72. PubMed ID: 15033377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.
    Whitehurst CE; Nazef N; Annis DA; Hou Y; Murphy DM; Spacciapoli P; Yao Z; Ziebell MR; Cheng CC; Shipps GW; Felsch JS; Lau D; Nash HM
    J Biomol Screen; 2006 Mar; 11(2):194-207. PubMed ID: 16490772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptor.
    Keov P; Valant C; Devine SM; Lane JR; Scammells PJ; Sexton PM; Christopoulos A
    Mol Pharmacol; 2013 Sep; 84(3):425-37. PubMed ID: 23798605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Search for lead structures to develop new allosteric modulators of muscarinic receptors.
    Tränkle C; Kostenis E; Burgmer U; Mohr K
    J Pharmacol Exp Ther; 1996 Nov; 279(2):926-33. PubMed ID: 8930201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological assessment of m1 muscarinic acetylcholine receptor-gq/11 protein coupling in membranes prepared from postmortem human brain tissue.
    Salah-Uddin H; Thomas DR; Davies CH; Hagan JJ; Wood MD; Watson JM; Challiss RA
    J Pharmacol Exp Ther; 2008 Jun; 325(3):869-74. PubMed ID: 18322150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.